⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5276473 | 0.64 | — | — | |
| SCHEMBL5276957 | 0.61 | — | — | |
| SCHEMBL4300029 | 0.49 | — | — | |
| SCHEMBL22689491 | 0.46 | — | — | |
| SCHEMBL4311227 | 0.46 | MEN1 (0.33) | — | |
| SCHEMBL13528411 | 0.46 | — | — | |
| SCHEMBL7135640 | 0.41 | — | — | |
| SCHEMBL42968 | 0.35 | GRIN2D (0.33) | — | |
| Hydrochloric Acid SCHEMBL4178849 | 0.32 | GRIN2D (0.31) | — | |
| SCHEMBL8573290 | 0.32 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115286587-A | High-delocalization alkali metal compound and preparation method and application thereof | 珠海中科先进技术研究院有限公司 | 2022-11-04 | — | — | CN | claimed |
| US-8852320-B2 | Preparation of metal-triazolate frameworks | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-10-07 | — | — | US | claimed |
| US-20120186449-A1 | PREPARATION OF METAL-TRIAZOLATE FRAMEWORKS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-07-26 | — | — | US | claimed |
| JP-6340640-A | — | — | None | — | — | JP | disclosed |
| CN-115286587-B | Highly delocalized alkali metal compound and preparation method and application thereof | 珠海中科先进技术研究院有限公司 | 2024-02-23 | — | — | CN | disclosed |
| US-11814348-B2 | Oxidizing liquid media for chemical transformations | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2023-11-14 | — | — | US | disclosed |
| CN-115286587-A | High-delocalization alkali metal compound and preparation method and application thereof | 珠海中科先进技术研究院有限公司 | 2022-11-04 | — | — | CN | disclosed |
| US-11396492-B2 | Direct oxidative amination of hydrocarbons | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2022-07-26 | — | — | US | disclosed |
| US-11078136-B2 | Oxidation of alkane to alkene | THE SCRIPPS RESEARCH INSTITUTE (US) | 2021-08-03 | — | — | US | disclosed |
| US-20210163503-A1 | OXIDIZING LIQUID MEDIA FOR CHEMICAL TRANSFORMATIONS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2021-06-03 | — | — | US | disclosed |
| US-10858301-B2 | Direct oxidation of olefins to oxygenated species | THE SCRIPPS RESEARCH INSTITUTE (US) | 2020-12-08 | — | — | US | disclosed |
| US-20120186449-A1 | PREPARATION OF METAL-TRIAZOLATE FRAMEWORKS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-07-26 | — | — | US | disclosed |
| EP-2125859-A2 | ESTRATRIENE DERIVATIVES AND THEIR USES AS 17BETA-HYDROXYSTEROID DEHYDROGENASE INHIBITORS | Solvay Pharmaceuticals GmbH (DE) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008034796-A2 | ESTRATRIENE DERIVATIVES AND THEIR USES AS 17BETA-HYDR0XYSTER0ID DEHYDROGENASE INHIBITORS | SOLVAY PHARMACEUTICALS GMBH (DE) | 2008-03-27 | — | — | WO | disclosed |
| EP-1859781-A2 | Brightening and/or colouring agent with triazoles | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-11-28 | — | — | EP | disclosed |
| EP-0518530-B1 | Improvements in or relating to excitatory amino acid receptor antagonists | LILLY CO ELI (US) | 1996-10-09 | — | — | EP | disclosed |
| JP-H06340640-A | PERFLUOROTRIAZINE DERIVATIVE AND ITS PRODUCTION | ASAHI GLASS CO LTD | 1994-12-13 | — | — | JP | disclosed |
| US-5196421-A | Treatment of neurological disorders | ELI LILLY AND COMPANY (US) | 1993-03-23 | — | — | US | disclosed |
| EP-0518530-A2 | Improvements in or relating to excitatory amino acid receptor antagonists | ELI LILLY AND COMPANY (US) | 1992-12-16 | — | — | EP | disclosed |
| US-5153196-A | Administering for reduction of neurotransmission in nervous system disorders | ELI LILLY AND COMPANY (US) | 1992-10-06 | — | — | US | disclosed |